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Abstract: Peripheral vascular disease affects some 12%–14% of the general population, and 
the majority of people with the disease are asymptomatic. The Ankle Brachial Pressure Index 
(ABPI) test is widely used by a diverse range of practitioners (in the community and hospital 
setting) in order to screen asymptomatic patients, diagnose patients with clinical symptoms, 
and to monitor patients who have had radiological or surgical intervention. This paper explains 
the theoretical basis of the ABPI test, as well as the relevance of the common modifications 
of the test. It explores the background to the quoted normal ranges for the ABPI test. It reviews 
the large body of literature that has developed on the association between ABPI and cardiovascu-
lar risk, as well as ABPI as a predictor for cardiovascular morbidity and mortality, highlighting 
the evidence that can inform practice. The review looks critically at the limitations of the ABPI 
test, providing practitioners with an evidence-based update on the importance and challenges 
of standardizing ABPI methodology. This paper highlights the influence of the key technical 
aspects of the ABPI test that all practitioners need to consider in order to be able to make more 
reliable and informed management decisions based on ABPI findings.
Keywords: ankle, brachial, pressure, index, ABPI, update
Introduction
The Ankle Brachial Pressure Index (ABPI) test is widely used in the setting of 
peripheral vascular disease by a diverse range of practitioners. The advantages and 
limitations of the ABPI test are not widely understood, and this review paper aims 
to inform and update practice by presenting the evidence about the performance of 
the ABPI test, allowing practitioners to make an evidence-based interpretation of 
ABPI findings.
Diagnosing peripheral vascular disease:  
the ABPI test
Peripheral arterial disease affects some 12% to 14% of the general popula-
tion. The prevalence of peripheral arterial disease is age-dependent, reaching 10% 
in people aged over 60 years,1,2 and some 20% aged over 75 years.3–5 Peripheral 
vascular disease is estimated to affect some 27 million people in Europe and North 
America.6
Unfortunately, the majority of patients are asymptomatic and undiagnosed; although 
intermittent claudication is the primary, and most often only, symptom, over 16 million 
of the patients with peripheral arterial disease are asymptomatic. Not only this, but one 
third of patients with symptoms do not report them to their doctor. As a result of this, Vascular Health and Risk Management 2009:5 834
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a high-risk group of patients are underdiagnosed and receive 
no (or suboptimal) treatment(s) or intervention(s).7,8
The Fontaine classification provides a framework 
for clinical staging (from I to IV) of peripheral vascular 
disease.9 However, given the large number of asymptomatic 
peripheral arteriopaths, relying on clinical history has a very 
low sensitivity for determining the presence of peripheral 
arterial disease. Fewer than 10% of patients with peripheral 
arterial disease will provide symptoms consistent with the 
Rose criteria for intermittent claudication.6,10 Criqui and 
colleagues11 claim that a history of intermittent claudication 
underestimates the presence of peripheral arterial disease 
by a factor of two to five. Similarly, Marinelli and 
colleagues12 claim that relying on an absent pedal pulse 
also underestimates the prevalence of disease. Hirsch and 
colleagues13 claim that clinicians who screen patients for 
peripheral arterial disease on the basis of finding a complaint 
of intermittent claudication will miss up to 90% of high-risk 
patients with the disease.
Therefore, given the limitations of relying on the clinical 
history or physical examination, an additional noninvasive 
test, the ABPI, has been widely adopted for confirmation 
of a clinical diagnosis of peripheral arterial disease and its 
quantification. The ABPI is a measure of the blood pressure in 
the arteries supplying legs relative to central, aortic pressure 
(approximated by measuring the blood pressure in the arm).
The Society for Vascular Technology14 has produced 
comprehensive laboratory guidelines for the measurement 
of ABPI, aiming to control the methodology under clinical 
conditions. Similarly, Vowden and colleagues,15 Stubbing 
and colleagues,16 Hiatt and colleagues,3 and McDermott 
and colleagues17 try to provide comprehensive methodology 
guidance for the measurement of ABPI.
In essence, ABPI is calculated by dividing the systolic 
blood pressure measured in the arterial conduits at the level 
of the ankle by the systolic blood pressure measured in the 
brachial artery as seen in the following equation:
  Ankle systolic blood pressure
Brachial systolic pressure ABPI =  
The ABPI is used to assess patients for peripheral arterial 
disease as a fall in blood pressure in an artery at the ankle 
relative to the central blood pressure would suggest a stenosis 
in the arterial conduits somewhere in between the aorta and 
the ankle.
Theoretical basis of the ABPI test
The idea of comparing peripheral systolic pressure with 
central systolic pressure was first introduced by Winsor18 using 
a mercury and rubber strain gauge method. The theoretical 
basis of ABPI is supported by obtaining ABPI ratios against 
findings in peripheral angiography,19–24 as well as from 
Doppler ultrasound as gold standard.25
ABPI is claimed to be a simple, noninvasive, and 
reproducible test.26–28 When used in university settings, 
ABPI measurements have been found to have good 
interobserver reliability between experienced physicians, 
with a reported κ-statistic of 0.77 to 1.0.29 Estimates of 
intraobserver variability range from 7.3%–12% for ABPI in 
the hospital26,27,30,32 as well as in the community setting.31,32 
Holland-Letz and colleagues33 point out that the previous 
studies of reliability had only small sample sizes of patients 
with disease; therefore they performed a large study in 
“normal” (asymptomatic) elderly patients (only two with low 
ABPI) and, by contrast, they found no differences in mean 
ABPI recordings between medical and nonmedical primary 
care practitioners; their estimate of intra- and interobserver 
error was 8% and 9%, respectively.
Similarly, Endres and colleagues34 found little interobserver 
variability (nearly zero) between different practitioner groups 
in a large study of unselected (asymptomatic) elderly patients. 
Well-controlled, repeat measurements of ABPI by expert 
practitioners are accurate enough to be used as a clinical 
gatekeeper in decision-making.27,30
The American Diabetes Association consensus paper35 
quotes the normal range of ABPI as being 0.91–1.3. This same 
consensus paper claims that mild disease falls into the range of 
0.7–0.9, whilst moderate ischemic disease is quoted for ratios 
of 0.41–0.69. Patients with mild or moderate disease will be 
claudicants. Ratios of less than or equal to 0.4 are quoted in 
severe disease, presenting clinically as critical ischemia.
Table 1 summarizes the Society for Vascular Technology’s14 
interpretation of resting ABPI measurements.
Understanding normal ranges 
for the ABPI test
Neither the Society for Vascular Technology14 nor the 
consensus paper35 explain how the limits of this normal 
ABPI range are derived. Male and colleagues36 claim that 
the majority of authors quoting ranges for ABPI refer back 
to original data from Yao and colleagues,22 Cornwall and 
colleagues,37 and Sumner.38 They also assert that there is a 
lack of evidence-based literature supporting the traditional 
interpretations of ABPI.
Male and colleagues36 point out that ABPI is age- and 
blood pressure-dependent (and these two factors are 
themselves linked). The accepted methodology of ABPI does Vascular Health and Risk Management 2009:5 835
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not make any corrections for physiological variation over 
time in baseline brachial systolic blood pressure, or other 
confounders for blood pressure measurement like respiratory 
phase necessitating a range to be used, rather than a point 
figure. It is easy to see that ABPI values over the upper limit 
of 1.3 may be associated with arterial incompressibility at 
the ankle (secondary to arterial wall medial calcification), 
a condition very commonly found in diabetics, renal patients, 
as well as a physiological function of age.14,35,39,40
It is less easy to explain why the lower limit of the normal 
ABPI ratio should ever be less than 1.0. In the normal 
individual, resting supine for at least ten minutes, the systolic 
blood pressure at the ankle will be slightly higher than the 
systolic blood pressure at the brachial artery. This is mostly 
due to the differences in the magnitude of pressure pulse 
reflections from the vascular beds immediately downstream 
of the ankle and elbow (ie, the vascular bed of the foot and 
that of the forearm and hand, respectively), but also partially 
because of the differences in distance between the point of 
measurement at the ankle and the elbow from the peripheral 
bed. The ankle is immediately proximal to a pressure antinode 
(the peripheral bed represented by the foot), whereas the 
elbow is one segment upstream from the analogous peripheral 
bed of the hand. Therefore one would assume from this that 
a normal ABPI ratio should be at least 1.0 or slightly more. 
And, in fact, Male and colleagues36 found that the mean 
normal ABPI in a small sample of young, healthy patients 
aged twenty to forty is 1.14, with a range of 1.05 to 1.25.
Ouriel and Zarins23 found that ABPI in a group of 
34 “normal” controls (asymptomatic, nondiabetic volunteers 
under 30 who had never smoked, and with triphasic Doppler 
waveforms) came to be 1.09 (±0.02 for 95% confidence 
windows). Carser41 claims that the normal corrected ABPI 
range is 1.02 to 1.78 (admittedly, Carser was studying 
ABPI ranges in the context of background hypertension). 
Of 100 studies of ABPI methodology included in their 
review, Klein and Hage42 found that the most frequently 
quoted normal value for ABPI was 1.0. Hiatt and colleagues3 
found the mean ABPI was 1.13 ± 0.08 (right leg) and 1.11 ± 
0.09 (left leg); later, Hiatt and colleagues43 derived a set of 
normal ranges for ABPI sub-classified according to sex, leg, 
and ankle vessel; all their data being drawn from a nondiabetic 
population screened to have low risk for peripheral vascular 
disease (men, right: dorsalis pedis 1.15 ± 0.11; posterior tibial 
1.19 ± 0.12; men, left: dorsalis pedis 1.14 ± 0.10; posterior 
tibial 1.18 ± 0.12; women, right: dorsalis pedis 1.09 ± 0.09; 
posterior tibial 1.13 ± 0.08; women, left: dorsalis pedis 
1.06 ± 0.10; posterior tibial 1.12 ± 0.08).
So why do the American Diabetes Association35 quote the 
lower limit of ABPI as 0.91? A number of groups, in fact, quote 
a range of abnormal lower cut-off points of less than 1.0, from 
0.80–0.98.2,3,19,44 An answer is partially deduced by looking 
again at ABPI methodology.14 Although all the most impor-
tant aspects have been standardized, the respiratory phase is 
not controlled during measurement of ABPI. Therefore it is 
perfectly possible to measure the systolic pressure at the ankle 
at peak expiration and coincidentally measure the systolic 
pressure at the brachial at peak inspiration. Respiration is 
well known to modulate blood pressure in mammals, with 
limited data from normal humans in one study suggesting a 
3% fall in systolic pressure during inspiration.45
As ABPI ranges are most likely the result of analyses of 
data from observational studies, the lower limit of 0.91 is 
therefore possibly a reflection of the inherent limitation of a 
noninvasive method of measuring blood pressure (using an 
occlusive cuff ) without controlling physiological variation 
from, for example, respiration. Beat-to-beat physiological 
variation in systolic blood pressure can only be controlled 
by synchronous measurements at the arm and ankle, which 
is cumbersome and not prescribed by any of the authoritative 
guides on ABPI measurement. Additionally, technical factors 
such as over-rapid deflation of the ankle cuff can also give 
artifactually low systolic pressure readings at the ankle.
Association between the ABPI 
ratio and cardiovascular morbidity 
and mortality
Having a low ABPI ratio is an independent risk factor for 
cardiovascular disease including fatal and nonfatal complica-
tions.46,47 In addition, the lower the ABPI value, the higher 
the risk of all-cause and cardiac mortality in patients with 
peripheral vascular disease.48
Table 1 interpretation of ABPi
Resting ABPI Severity of disease
1.4 Calcification may be present
1.0 Probably no arterial disease
0.81–1.00 No significant arterial 
disease, or mild/insignificant 
disease
0.5–0.80 Moderate disease
0.5 Severe disease
0.3 Critical ischemia
Notes: Copyright © 2001, institute of Physics and engineering in medicine.   Adapted 
with permission from Cole SeA. editor. Vascular Laboratory Practice (Part III). 1st ed. 
London, UK: iPeM; 2001. p. 36.
Abbreviation: ABPi,   Ankle Brachial Pressure index.Vascular Health and Risk Management 2009:5 836
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The predictive value of ABPI in cardiovascular morbidity 
and mortality is similar to that of traditional Framingham risk 
factors.49 McKenna and colleagues50 evaluated a low ABPI as 
an independent risk factor for mortality. Doobay and Anand51 
found that low ABPI was highly specific for predicting 
future cardiovascular events. A recent meta-analysis found 
that ABPI is an independent risk factor for cardiovascular 
mortality alongside the traditional Framingham risk factors, 
and having an ABPI of 0.9 resulted in a doubling of 
cardiovascular mortality and morbidity across all of the 
Framingham risk categories; furthermore, combining 
ABPI with traditional Framingham risk assessment would 
re-classify 19% of men and 36% of women into more 
appropriate treatment categories.52
An ABPI ratio of less than 0.9 has been associated with 
up to a three-fold relative increase in all-cause and cardiac 
mortality, in both men and women.50,53–55
Similarly, having an elevated ABPI  1.40 (even if the 
observation was nondiagnostic because of arterial incom-
pressibility secondary to calcification) is a predictor for an 
increase in all-cause mortality as well as cardiovascular 
mortality.56
The association between peripheral arterial disease and 
increased mortality is a result of the fact that the underlying 
pathological process, atherosclerosis, is a systemic one. 
Atherosclerosis, if present in the periphery, is also likely 
in other parts of the arterial tree. Ness and Aronow57 found 
that 68% of patients with peripheral arterial disease also had 
coronary artery disease in an elderly population. Patients 
with peripheral arterial disease have more than a sixfold 
increase in the risk of death from coronary artery disease 
when compared to patients without the disease.53 Even if 
patients with peripheral arterial disease are asymptomatic, 
they have an increased risk of future cardiac and cerebro-
vascular events, as well as being six times more likely to die 
within ten years when compared to healthy individuals.58 
A number of groups support the use of ABPI not only as 
a diagnostic tool, but also as a risk assessment tool in the 
setting of peripheral vascular disease.59–61
Modifications of the ABPI technique
The literature is replete with validations of modifications 
or refinements of traditional ABPI methodology or its 
calculation.62,63
Clinically, the most common addition to the resting 
ABPI is that of postexercise measurements. Carter64 
claimed that exercise testing would unmask patients with 
mild peripheral vascular disease (ie, patients with degrees 
of diameter reduction in the arteries of less than 50%). 
Some researchers claim that resting ABPI correlates 
well with functional walking capacity in patients with 
peripheral arterial disease.65–67 Szuba and colleagues68 out-
right reject this position, claiming that only postexercise 
ABPI, and not ABPI itself (or other resting hemodynamic 
measures) has any predictive ability for or correlation 
with walking distance in peripheral arterial disease. The 
value of exercise testing (over and above resting ABPIs) 
was questioned by Allen and colleagues25 and Ouriel and 
colleagues.44
Allen and colleagues25 compared resting and postexercise 
ABPI to color Duplex ultrasound (as gold standard). When 
postexercise ABPI measurements were used in addition 
to resting ABPI, the correlation with color Duplex ultra-
sound for detecting significant arterial disease increased 
by only 2% (from 83% for resting ABPI alone to 85% 
in the combined resting and postexercise ABPI method). 
However, the clinical utility of any exercise test is limited 
in bilateral disease by the most symptomatic limb in the 
patient; and Stein and colleagues69 point out that exercise 
testing is not even an option in patients with poor mobility 
due to comorbidity (eg, cardiac disease, respiratory disease, 
or disability). Hiatt and colleagues3 estimated that at 
least 15% of patients were unsuitable for exercise testing 
or hyperemia induction (simulating exercising with an 
occlusive cuff ).
Limitations of ABPI
In their original paper on ankle systolic pressures, Yao and 
colleagues22 claimed 98% overall accuracy (sensitivity 
97%, specificity 100%) against angiography using an 
ABPI threshold of 1.0 as being normal. This pioneering 
work, preceded by that of Carter,19 assumed an ABPI 
threshold of 1.0 using normal (clinically asymptomatic) 
volunteers as controls, rather than angiographically-proven 
normals.
Other papers from the same authors20,21 as well as that 
from Ouriel and Zarins23 make similar claims for accuracy, 
but these studies also rely on the same the type of control 
group (normal volunteers rather than angiographically-proven 
normals).
Later, Allen and colleagues,25 using color Duplex 
ultrasound as the gold standard in nondiabetic patients 
with peripheral vascular disease, came up with an overall 
figure of 83% accuracy using an ABPI threshold of 0.8. 
This study used patients who could tolerate both a resting 
ABPI and an exercise ABPI. The data did not include any Vascular Health and Risk Management 2009:5 837
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normal volunteers. Agreement with Duplex ultrasound 
was shown to drop in patients with higher ABPI values, 
down to 76% in patients with ABPIs of 0.9. At the same 
time, Allen and colleagues25 found 100% agreement with 
Duplex ultrasound in patients with an ABPI  0.6. Allen 
and colleagues25 concluded that “ABPI is biased toward the 
detection of more severe disease and is more consistent with 
colour Duplex ultrasound when the most symptomatic limbs 
are compared”. Therefore in the clinical setting, where it is 
possible to do an ABPI on patients with peripheral vascular 
disease, up to 17% of these ABPI tests might be unreliable.
Belch and colleagues7 point out that it is also possible 
to have a high-grade aorto-iliac stenosis or occlusion clini-
cally masked by a rich collateral network; in these situations, 
using ABPI would also fail to unmask the underlying lesion. 
In fact, Belch and colleagues7 highlight the wider problem 
that nearly 60% of patients with peripheral arterial disease 
are asymptomatic, and if collateral vessels are the reason, 
they are likely to be unreliable candidates for identification 
by the ABPI test.
Stein and colleagues69 question the utility of the ABPI 
test in patients with low-grade stenosis after reporting 
that nearly half of all patients with symptoms of periph-
eral arterial disease had a normal resting ABPI. Although 
Stein and colleagues69 concede that some of these patients 
will have intermittent claudication or ulceration from 
another cause, they also point out that the original studies 
on ABPI were limited to patients with advanced disease. 
Ouriel and Zarins23 did not find a significant difference 
between ABPI for asymptomatic patients and patients 
with angiographically-proven nonocclusive disease.
At the other end of the clinical spectrum, in certain 
groups of patients at high risk of heavy arterial calcification, 
ABPI becomes impractical and nondiagnostic. For example, 
in elderly, diabetic and renal patients (and also other groups 
with rarer systemic diseases, like systemic sclerosis, 
or rheumatic diseases) calcification of the peripheral arteries 
can make the arteries incompressible, and therefore the 
ABPI test (relying on measurement of systolic pressure with 
an occlusive cuff) becomes nondiagnostic or inaccurate due 
to artefactually-raised occlusion pressures secondary to 
medial calcification in the arterial wall.70
This is all the more problematic since, in some of these 
subgroups of patients, peripheral arterial disease is common. 
Estimates of the prevalence of peripheral arterial disease in 
diabetic patients vary from 33% to 50%.3,71
In diabetic patients, it is not uncommon to use a pressure 
cuff at 300 mmHg and still fail to occlude an artery at the 
ankle due to calcification and hardening of the arterial 
wall. Raines and colleagues72 estimated that occlusive 
ankle pressures could not be measured in 5%–10% of 
diabetic patients. Therefore, for a group of patients with 
long-standing diabetes, or renal failure, presenting with 
peripheral vascular symptoms, and in whom ABPI is 
nondiagnostic, there is a need for a noninvasive, clinical 
alternative to ABPI for assessing the presence of significant 
arterial disease.
Standardizing ABPI methodology
The exact methodology of ABPI is far from standardized 
on a large number of technical aspects, starting with 
the choice of artery at the ankle. Because there are three 
arteries at the ankle, ABPI can be calculated in a number 
of ways and combinations eg, based on using the highest 
pressure,44,73 the lowest pressure,74 the best Doppler single,24 
or a combination of ankle vessel pressures.43 The Society for 
Vascular Technology allows practitioner to choose between 
two prescribed methods for the ankle systolic.14 Similarly, 
it is possible to measure pressure in either arm, and there 
is no consensus position on how central pressure should 
be approximated from the arm pressure. Both Carter21 
and Sumner38 pointed out that atherosclerosis is systemic 
and can therefore affect the pressure in the upper limbs 
directly or indirectly via disease in the aortic arch. Grim75 
pointed out that, the length of the rest period, “patient-white 
coat” phenomena, cuff placement, cuff size, and the speed of 
inflation/deflation can affect blood pressure recordings – all 
of which are relevant to the context of ABPI. In patients 
who cannot lie supine, a further inaccuracy is added by the 
hydrostatic pressure difference between the arm and leg.76 
The definition of “resting” (as part of the resting ABPI) is 
also important; patients with severe multilevel arterial disease 
need a longer period of “rest” prior to taking systolic pressure 
measurements and this is difficult to know beforehand.77 
Doppler probe selection (with respect to frequency, and level 
of quality assurance maintenance) can also be a source of 
inconsistency between practitioners.76
Apart from the inconvenience and difficulty of controlling 
a large number of environmental factors that can affect vaso-
motor tone (eg, temperature) and therefore blood pressure 
readings, there is also an intrinsic, physiological variability 
found in blood pressure measurements (and their ratios, like 
ABPI) so that some authors have recommended multiple 
measurements to allow consistent longitudinal follow-up, 
and to dismiss changes of less than 0.15 in serial readings 
of the ABPI ratio.78,79Vascular Health and Risk Management 2009:5 838
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Interestingly, Holland-Letz and colleagues33 pointed out 
that the validity of noninvasive blood pressure measurement 
(by whatever method) in the context of ABPI has never been 
assessed (eg, compared in real time against the invasive blood 
pressure reading in a controlled setting).
Furthermore, when measuring blood pressure using an 
occlusive cuff, there is a reduction in blood flow through 
any proximal lesion at the moment of systolic pressure 
measurement, thereby giving an underestimate of true rest-
ing pressure drop across the lesion. Hence the occlusive cuff 
method on which ABPI relies is liable to underestimate the 
presence of peripheral arterial disease. This underestima-
tion of true pressure drop is most marked when the lesion is 
immediately proximal to the ankle cuff.80–82
As of yet, there is no consensus agreement on the 
methodology for ABPI, and no vessel-specific criteria for 
the diagnosis of peripheral vascular disease. Carser41 found 
that the ABPI ratio was influenced by whether patients had 
baseline hypotension or hypertension (as represented by the 
brachial systolic pressure), and that baseline systemic pres-
sure was therefore a confounder of ABPI measurement. Klein 
and Hage42 try to make sense of the diverse methodologies in 
practice for measuring ABPI and try to synthesize a standard 
approach. They identify a long list of technical factors (see 
Table 2 below) that can confound serial ABPI values and 
make empirical recommendations for their standardiza-
tion. They point out, rightly, that without standardization, 
studies using ABPI testing cannot be compared to each other 
adequately. And patients moving from centre to centre might 
find their ABPI drifts as well.83
Klein and Hage42 point out that there is no agreement 
on the precise normal value (or normal range) for ABPI, 
not least due to methodological inconsistencies between 
groups; some authorities apply a lower limit of ABPI for 
the absence of disease, some apply an upper limit for the 
presence of disease, and others still consider both these 
limits to be one and the same (so defining a point value for 
ABPI below which there is disease, and above which disease 
is absent). When trying to relate ABPI to symptomatic 
patients who complained of intermittent claudication, Yao 
and colleagues77 found that the ABPI varied from between 
0.2 to 1.0 in these patients.
Notably, Hiatt and colleagues4 add that, in any case, all 
“normal” ranges for ABPI need to be corrected for sex, order 
of measurement of the limbs, and which ankle vessel(s) is/are 
being used for the calculation.
As a result of the lack of consensus on standardization, 
the accuracy and repeatability of ABPI readings has certainly 
been questioned in the literature, especially between diseased 
(symptomatic) and “normal” (asymptomatic) patient groups, 
and for nonexpert and expert practitioners.27,84–88 Vowden 
and Vowden76 surveyed nurse practitioners and found poor 
understanding of the methodological requirements for 
accurate and reproducible ABPI measurement, as well as a 
lack of awareness of its limitations. It is interesting to note 
that ABPI has not been included in the UK Department of 
Health’s five-yearly screening program for vascular risk for 
those aged 40–74 years.89
Furthermore, ABPI has been found to be insensitive 
to detecting progression of atherosclerosis. In a study by 
McLafferty and colleagues,90 ABPI had a sensitivity of 
41%, a specificity of 84%, and an overall accuracy of 68% 
for detecting changes in peripheral arterial disease status 
compared to catheter angiography and duplex ultrasound 
imaging (as gold standards), leading the authors to recom-
mend that imaging studies are superior to ABPI to monitor 
the progression of peripheral vascular disease.
Conclusion
Although regarded as a routine test, a great deal of further 
work is required before a consensus can be reached on a 
standardized technique for ABPI. A practitioner should be 
familiar with the evidence around the theoretical basis for the 
ABPI test in order to make evidence-based interpretations 
of the results. In particular, practitioners need to be aware of 
the technical limitations of using ABPI and how variations in 
ABPI methodology can affect the findings. In certain com-
mon clinical situations, for example diabetic patients with 
calcified ankle arteries, ABPI can give artifactual results, or 
be nondiagnostic altogether. In these cases, practitioners need 
to consider alternative tests to confirm or exclude peripheral 
vascular disease.
Table 2 Nonstandard aspects of ABPi measurement42
Position of patient during measurement
width and level of sphygmometer cuffs
Use of Korotkoff method vs Dinamap vs Doppler probe to define 
systolic pressures
whether to use both brachial pressures or not in calculation of ABPi
whether to use all three crural vessels, two, or just one in calculation 
of ABPi
whether to use highest or mean values of pressure in calculation 
of ABPi
Normal ranges for ABPi ratios
Abbreviation: ABPi,   Ankle Brachial Pressure index.Vascular Health and Risk Management 2009:5 839
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